Tag: CDY
Cellmid set to commercialise 15 minute diagnostic test for COVID-19
Life sciences company Cellmid (ASX: CDY) is set to come out of its self-imposed trading halt on Monday with news that it will commercialise...
Cellmid prepares to receive Chinese patent covering évolis range
Life sciences company Cellmid (ASX: CDY) has told the market it is tentatively expecting to receive a patent from the Chinese Patent Office for its évolis...
Cellmid launches evolis hair products into Europe and China via new distribution agreements
Cellmid (ASX: CDY) has launched into Europe after securing a distribution agreement with Douglas GmbH for its evolis professional anti-aging hair care and hair...
Cellmid predicts record second quarter revenue after successful Japanese sales campaign
Australian life sciences company Cellmid (ASX: CDY) has reaped a revenue of approximately $1.1 million from a scheduled sales event for its Jo-Ju hair...
Cellmid’s anti-midkine study holds promise for chronic kidney disease patients
Australian life sciences company Cellmid (ASX: CDY) has announced positive efficacy results of a study using its anti-midkine antibody CAB102 in the treatment of...
Cellmid executes pincer movement to distribute cornerstone évolis product into both China and the US
With the US-China trade war brewing in the background, life sciences company Cellmid (ASX: CDY) has secured a deal to sell its évolis product...
Cellmid agrees distribution deal with Bloomingdale’s to stock évolis professional range
Life sciences company Cellmid (ASX: CDY) has secured a potentially money-spinning partnership with Bloomingdale's, a prominent US retailer, for the sale of its évolis...
Positive study results for Cellmid’s évolis hair growth products
Cellmid Limited (ASX: CDY) has reported positive results following the completion of its first consumer experience study using the evolis® Professional product range.
All but...
